These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 7858911

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Antioxidants, lipoprotein oxidation, and arterial function.
    Bruckdorfer KR.
    Lipids; 1996 Mar; 31 Suppl():S83-5. PubMed ID: 8729099
    [Abstract] [Full Text] [Related]

  • 23. Oxidation of lipoproteins and atherosclerosis.
    Luc G, Fruchart JC.
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Atherosclerosis. Description and mechanisms. Part 2: mechanisms].
    Capron L.
    Rev Neurol (Paris); 1983 Jan; 139(4):239-50. PubMed ID: 6612139
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Patho- and morphogenesis of atherosclerosis (clinico-experimental aspects)].
    Anestiadi VKh, Nagornev VA.
    Arkh Patol; 1984 Jan; 46(3):10-8. PubMed ID: 6721700
    [Abstract] [Full Text] [Related]

  • 29. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima.
    Leeuwenburgh C, Hardy MM, Hazen SL, Wagner P, Oh-ishi S, Steinbrecher UP, Heinecke JW.
    J Biol Chem; 1997 Jan 17; 272(3):1433-6. PubMed ID: 8999808
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Lipoprotein responses and artery wall responses as factors affecting the development of atherosclerosis.
    Kummerow FA.
    Ann N Y Acad Sci; 1985 Jan 17; 454():46-51. PubMed ID: 3865614
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Metabolism of lipoproteins labeled with fluorescent indocarbocyanine dyes for in vitro studies of atherogenesis.
    Reynolds GD.
    Surv Synth Pathol Res; 1985 Jan 17; 4(5-6):389-400. PubMed ID: 3939385
    [No Abstract] [Full Text] [Related]

  • 38. Cell-mediated oxidation of LDL: comparison of different cell types of the atherosclerotic lesion.
    Müller K, Carpenter KL, Mitchinson MJ.
    Free Radic Res; 1998 Sep 17; 29(3):207-20. PubMed ID: 9802552
    [Abstract] [Full Text] [Related]

  • 39. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis.
    Heinecke JW.
    Curr Opin Lipidol; 1997 Oct 17; 8(5):268-74. PubMed ID: 9335950
    [Abstract] [Full Text] [Related]

  • 40. The influence of platelet-smooth muscle cell interaction on the oxidative modification of low-density lipoprotein.
    Alexander JJ, Lewis I.
    J Surg Res; 2002 Mar 17; 103(1):41-6. PubMed ID: 11855916
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.